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Available online 3 October 2017Objective: Assessment of calcaneus microstructure using high-resolution peripheral quantitative computed to-
mography (HR-pQCT)might be used to improve fracture risk predictions or to assess responses to pharmacolog-
ical and physical interventions. To develop a standard clinical protocol for the calcaneus, we validated calcaneus
trabecular microstructure measured by HR-pQCT against ‘gold-standard’ micro-CT measurements.
Methods: Ten human cadaveric feet were scanned in situ using HR-pQCT (isotropic 82 μm voxel size) at 100, 150
and 200 ms integration times, and at 100 ms integration time following removal of the calcaneus from the foot
(ex vivo). Dissected portions of these bones were scanned using micro-computed tomography (micro-CT) at
an isotropic 17.4 μmvoxel size. HR-pQCT imageswere rigidly registered to those obtainedwithmicro-CT and di-
vided into multiple 5 mm sided cubes to evaluate and compare morphometric parameters between the modal-
ities. Standard HR-pQCT measurements (derived bone volume fraction (BV/TVd); trabecular number, Tb.N;
derived trabecular thickness, Tb.Thd; derived trabecular spacing, Tb.Spd) and corresponding micro-CT voxel-
based measurements (BV/TV, Tb.N, Tb.Th, Tb.Sp) were compared.
Results:A total of 108 regions of interestwere analysed across the 10 specimens. At all integration times HR-pQCT
BV/TVd was strongly correlated with micro-CT BV/TV (r2 = 0.95–0.98, RMSE= 1%), but BV/TVd was systemati-
cally lower than that measured by micro-CT (mean bias = 5%). In contrast, HR-pQCT systematically
overestimated Tb.N at all integration times; of the in situ scans, 200 ms yielded the lowest mean bias and the
strongest correlation with micro-CT (r2= 0.61, RMSE= 0.15mm−1). Regional analysis revealed greater accura-
cy for Tb.N in the superior regions of the calcaneus at all integration times in situ (mean bias= 0.44–0.85mm−1;
r2= 0.70–0.88, p b 0.001 versusmean bias=0.63–1.46mm−1; r2 ≤ 0.08, p ≥ 0.21 for inferior regions). Tb.Spdwas
underestimated byHR-pQCT compared tomicro-CT, but showed similar trends with integration time and the re-
gion evaluated as Tb.N. HR-pQCT Tb.Thd was also underestimated and moderately correlated (r2 = 0.53–0.59)
with micro-CT Tb.Th, independently from the integration time. Stronger correlations, smaller biases and error
were found in the scans of the calcaneus ex vivo compared to in situ.
Conclusion: Calcaneus trabecular BV/TVd and trabecular microstructure, particularly in the superior region of the
calcaneus, can be assessed by HR-pQCT. The highest integration time examined, 200 ms, compared best with
micro-CT. Weaker correlations for microstructure at inferior regions, and also with lower integration times,
might limit the use of the proposed protocol, which warrants further investigation in vivo.
© 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Keywords:
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. This is an open access article under1. Introduction
Osteoporosis is characterized by a deterioration of bone mass and
microstructure, resulting in loss of bone strength and increased risk of
fracture [1]. Dual-energy X-ray absorptiometry (DXA) areal bonethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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oporosis, either alone or increasingly combined with an evaluation of
risk factors independent of BMD as in tools such as FRAX [2]. The
two-dimensional representation of bone properties captured by DXA
measurements limits the technique's sensitivity to changes in bonemi-
crostructure with disease and with treatments for osteoporosis man-
agement. Clinical research studies have recently beneﬁtted from being
able to study bone microstructure using a signiﬁcantly lower ionizing
radiation dose and higher spatial resolution compared to standard
quantitative computed tomography (QCT) at the spine and hip [3].
Such High-Resolution peripheral QCT (HR-pQCT) can identify trabecu-
lar and cortical microstructural abnormalities and mechanical deﬁcien-
cies associated with fracture risk [4–6], and appear sensitive to changes
induced by some treatments for osteoporosis [7–9].
The HR-pQCT scan has been performed primarily at the distal radius
and distal tibia. Other sites have been scanned using HR-pQCT, such as
the metacarpal joints [10,11] and there have been new developmental
investigations at the knee [12]; these highlight quantitative outcomes
that could be useful in areas other than osteoporosis research. The calca-
neus (heel bone) has been widely investigated in osteoporosis, particu-
larly using the attenuation of ultrasonic waves from quantitative
ultrasound (QUS). The latter appears to provide microstructural infor-
mation independent of BMD [13,14] and can predict vertebral and
non-vertebral fracture risk [15]. However, there have been validity is-
sues using QUS, speciﬁcally associated with its precision over time
[16] and inter-device differences [17]. DXA scanning could be used in
the calcaneus, however this would still suffer from the inherent limita-
tions of arealmeasurements. In podiatry research, clinical computed to-
mography (CT) has been used to model the calcaneus and surrounding
bones of the foot [18,19] and to clinically examine calcaneal fractures. In
the assessment of calcaneusmicrostructure, measurements frommulti-
detector CT scans, with an in-plane pixel size of 208 μmand 500 μmslice
thickness, have been weakly correlated (r2 ≤ 0.51) to measurements
from micro-CT scans (16 μm voxel size) [20]. The use of HR-pQCT
scans with a voxel size of 61 to 82 μmmay improve the quantiﬁcation
of calcaneus microstructure in vivo and could therefore be of interest
to the osteoporosis and podiatry ﬁelds; to our knowledge a method to
scan the calcaneus using HR-pQCT has not been reported in vivo.
Distal radius and tibia trabecular and cortical microstructural and
biomechanical HR-pQCTmeasurements have been validated in compar-
ison to scans obtained using micro-CT [21–25]. Compared to the radius
and tibia, the calcaneus is anatomically and structurally different; it is
the largest tarsal bone and has several close-lying bones of the foot
(talus, navicular and cuboid). Additionally, it is characterized by a thin
cortex containing trabecular bone. We therefore aimed to develop a
protocol to scan the calcaneus using HR-pQCT and validate measure-
ments of trabecular microstructure. Speciﬁcally, we wanted to
determine the accuracy of trabecular BV/TV andmicrostructure in calca-
neus HR-pQCT scans with respect to ‘gold standard’micro-CTmeasure-
ments, and to explore the impact of scan integration time (i.e. the
duration of each tomographic projection) on structural parameters.
2. Methods
2.1. Materials
Ten lower limbswere obtained from cadavers (n=5, all female, age
range 85 to 101 years) that had consented in life and were donated to
the University of Shefﬁeld for anatomical study. The cadavers had un-
dergone standard embalming, which has been reported to have a min-
imal effect on BMD [26], and the limbs were divided through the
proximal 2/3 point of the tibia. The use of the limbs was carried out
under direct supervision of the Designated Individual, authorised
under the Human Tissue Act and the limbs were returned after use.
No medical history was available and specimens were not examined
for the presence of metabolic bone disease. Ethical approval wasprovided by the Medical School Research Ethics Committee at the Uni-
versity of Shefﬁeld (reference number 007375).
2.2. HR-pQCT scanning
The embalmed specimens were kept in sealed polythene bags dur-
ing HR-pQCT scanning. Specimens were positioned in the carbon ﬁber
foot cast that is normally used for the distal tibia HR-pQCT scan. The
feetwere positioned so that the superior and inferior surfaces of the cal-
caneus were parallel to the reference line that was positioned to start
the scan: this enabled a series of lateral slices of the calcaneus to be ob-
tained. In vivo, thiswould require a body and lower-limbposition equiv-
alent to the distal tibia HR-pQCT scan, but with plantar-ﬂexion at the
ankle. Scans of the whole calcaneus were obtained between the superi-
or peak of the tuberosity and the plantar fascia attachment to the calca-
neal tuberosity at an isotropic voxel size of 82 μm (maximum of 660
slices) using the standard clinical operational settings: 60 kVp and
95 mA collecting 750 projections over a 180° rotation of the X-ray
source (XtremeCT I, SCANCO Medical AG; Brüttisellen, Switzerland).
As part of the method development, each calcaneus was scanned with
different integration times; in situ (with the calcaneus in the intact
limb) scan projections were collected twice at 100 ms and once each
at 150 and 200ms integration times, labelled IS100, IS150 and IS200, re-
spectively. The range of integration times was tested to determine the
potential gains in microstructure assessment of more prolonged expo-
sure, while limiting the upper scan time to 4.2 min to minimize poten-
tial movement artifacts when the protocol would be used in vivo in
future clinical settings. Isolated (ex-vivo, with the calcaneus removed
from the limb, soft tissue removed but no cleaning of the bonemarrow)
scan projections were collected at 100 ms integration time, labelled
EV100, to determine whether measurements would be affected by the
surrounding bones of the foot. For these scans, the calcaneal samples
were placed in sealed polythene bags and supported by foam, in order
to obtain a similar anatomical position to scans in situ.
Image reconstruction followed the manufacturer's standard
methods. The reconstructed linear attenuation was mapped onto a
1536 × 1536 matrix and converted to hydroxyapatite (HA) densities.
Calibrations of the densities were performed on a daily basis using a
phantom supplied by the manufacturer, which has HA rods at 0, 100,
200, 400 and 800 mg HA/cm−3 embedded in resin.
2.3. Micro-CT scanning
The dissected calcanei were cut into rectangular prism samples (18
× 18 × 40mm) preserving cortical bone at the superior and inferior sur-
faces, using a diamond-coated bandsawunder constant water irrigation
(EXAKT, GmbH; Norderstedt, Germany). Each sample was submerged
and ﬁxed in a 50 ml holder containing saline solution and was
vacuumed for 20 min to remove air bubbles prior to each scan.
Each sample was scanned at an isotropic voxel size of 17.4 μm using
a SkyScan 1172 desktop micro-CT system (Brüker; Kontich, Belgium).
Settings for image acquisition were 100 kVp, 100 μA, 2950 ms integra-
tion time, 2 frames averaged, 1.0mmaluminumﬁlter and a 0.7° rotation
step. Scans were reconstructed using the NRECON software, according
to the manufacturer's recommendations: ring artifact was set to 10,
beam hardening to 30%, 16-bit DICOMs as applied in a recent study of
human trabecular bone [27].
2.4. Rigid image registration
HR-pQCT scan DICOMs were registered to their respective micro-CT
scans in a two-step process (Amira 6.0, FEI; Oregon, USA): step 1, an
IS100 HR-pQCT scan was pre-aligned and registered to the micro-CT
scan using a normalized mutual information metric and resampled
using a Lanczos interpolator. The Lanczos interpolator has been applied
to transform micro-CT scans of small animals [28,29]. A preliminary
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HR-pQCT scans (Supplemental material 1). In step 2, the remaining HR-
pQCT scans (IS100, IS150, IS200 and EV100) were registered using sim-
ilar settings to the pre-registered IS100 HR-pQCT scan. This spatially
registered all HR-pQCT scans to the micro-CT scan and, importantly, to
the same reference system. The HR-pQCT scans from step 2 were used
for morphological evaluation.
2.5. HR-pQCT and micro-CT evaluation
A custom cropping procedure was performed at the common region
between the scanmodalities, along the superior-inferior axis. The aimof
the procedurewas to increase the likelihood of evaluating awider range
of BV/TV [25,30] as there had been signiﬁcant bone loss in some speci-
mens. Images were divided into regions of interest approximately 5
× 5 × 5 mm in dimensions: HR-pQCT, 60 × 60 × 60 voxels and micro-
CT 284 × 284 × 284 voxels (Fig. 1). 24 cubical regions of trabecular
bone were isolated in each scan, virtually dividing the central portion
of each micro-CT image in six 5 mm thick slices, which were divided
into four cubes (Fig. 1). All registered HR-pQCT scans and the micro-
CT scans were then imported into an XtremeCT workstation and evalu-
ated using the SCANCO Image Processing Language (IPL 5.08-B).
HR-pQCT scans were evaluated using the standard patient analysis;
this uses a Laplace-Hamming ﬁlter to smooth the image and enhance
edges, and then applies a 40% ﬁxed global threshold to segment the
bone from marrow phase [31]. The following measurements were ex-
tracted from the images: trabecular volumetric BMD (Tb.vBMD), de-
rived trabecular BV/TV (BV/TVd; Tb.vBMD/1200), trabecular number
(Tb.N) using ridge extraction methods [32] and derived trabecular
thickness (Tb.Thd; BV/TVd/Tb.N) and spacing (Tb.Spd; (1-BV/TVd)/
Tb.N) using plate-model assumptions [33,34].
Micro-CT scans underwent a Gaussian ﬁlter (kernel 1.2, support 2)
to reduce the high frequency noise and were segmented using a sin-
gle-level, global threshold (330/1000) based on a visual inspection of
each specimen. Four individual regions from the same specimen hadFig. 1.Methodology for registration and identifying the cubed regions of interest for HR-pQCT an
image (red). Examples of the micro-CT and HR-pQCT images following transformation are sho
× 5 mm regions along the superior-inferior axis. The 6 regions were sub-divided into four equal
of the 10 × 10 × 5 mm regions were combined into superior, middle and inferior regions: there
to 8; middle = region 9 to 16; inferior = region 17 to 24.an adapted threshold (350/1000) after visually checking the segmented
scan images. A despeckle algorithm was applied to remove isolated
bone regions with a volume lower than 10 voxels. BV/TV was deter-
mined by dividing the number of bone voxels (BV) by the total number
of voxels in the region of interest (TV). Trabecularmicrostructure (Tb.N,
Tb.Th and Tb.Sp) were calculated using the distance transformation
method, where maximal spheres are ﬁlled into the segmented image
[35]. Examples of the HR-pQCT and micro-CT scans segmentation are
presented in Fig. 2.2.6. Statistical analysis
Statistical analyses were completed in GraphPad Prism (7.0,
GraphPad Software: La Jolla California, USA) and R Studio (1.0.44: Bos-
ton, USA). A p b 0.05 indicated statistical signiﬁcance, unless stated oth-
erwise. Morphometric measurements were non-normally distributed
following visual and statistical checks (Shapiro-Wilk test), therefore
median and interquartile rangeswere calculated for eachmeasurement.
Wilcoxon-Rank tests were performed to compare the paired HR-pQCT
and micro-CT scans (IS100, IS150, IS200, EV100 vs. micro-CT).
Friedman's testwith post-hoc between-pair analyses usingDunn'smul-
tiple comparisons tests was performed to compare the four HR-pQCT
scans.
Linear regression analyses were performed to evaluate the correla-
tion between the measurements performed on the HR-pQCT and
micro-CT images; coefﬁcient of determination (r2), equation slope and
intercept, root mean square error (RMSE) and the largest difference be-
tween the predicted and morphological parameters (max. error) were
calculated. A region was treated as an outlier and removed from the re-
gression analyses if all comparisons (IS100, IS150, IS200 and EV100)
exceeded the Cook's distance (4/number of regions). Regression slopes
were compared between the HR-pQCT scans using a one-way ANOVA
and t-tests with Bonferroni corrections, to account for multiple tests
i.e. between scan conditions (0.05/4) and between regions (0.05/3).d micro-CT image analysis. A) The HR-pQCT images were rigidly registered to the micro-CT
wn in all 3 planes (sagittal, transverse and coronal). B) Scans were split into six 10 × 10
sized cubed volumes of interest (5 × 5 × 5 mm), which were used in the evaluations. Two
were eight 5 × 5 × 5 mm-cubed volumes of interest in these regions. Superior = region 1
Fig. 2. Segmentation of representative regions of interest in the calcaneus using HR-pQCT andmicro-CT. A slice is shown for a representative HR-pQCT andmicro-CT image. The HR-pQCT
scan is separated into the condition (in situ (IS) and ex vivo (EV)) and scan integration time (100, 150 and 200 ms). This includes a grayscale and segmented slice, and the 3D volume of
interest.
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between the paired HR-pQCT scans and the micro-CT scan [36].
3. Results
3.1. Descriptive comparisons
In total, 108 matched regions were evaluated between all HR-pQCT
scans and the micro-CT scans, after removal of HR-pQCT scans with vis-
ible air bubbles or negative Tb.vBMD values. Table 1 contains the de-
scriptive statistics for the morphological measurements from the
scans. All estimates of BV/TVd, Tb.Thd and Tb.Spd derived from HR-
pQCT images (IS100, IS150, IS200 and EV100) were signiﬁcantly lower
than the corresponding measures obtained from micro-CT images (all
p b 0.001). In contrast, Tb.Nmeasured in all HR-pQCT imageswas signif-
icantly overestimated (p b 0.001)when compared to themicro-CTmea-
surements. No differences were found among the Tb.vBMD and BV/TVdTable 1
Descriptive statistics for the micro-CT and HR-pQCT scan imag
Abbreviations: in situ 100 ms (IS100); in situ 150 ms (IS150); i
vBMD (Tb.vBMD), bone volume fraction (BV/TV), trabecular num
(Tb.Sp).
N=108matched regions. Data are presented asmedian (25%,
were directly measured.
Measurements in bold are signiﬁcantly different to all HR-pQC
p b 0.001 compared to a IS150, b IS200 and c EV100.measurement performed on the in situ HR-pQCT images across the 3
integration times, but Tb.N, Tb.Thd and Tb.Spd measured from IS100,
IS150 and IS200 images were all signiﬁcantly different to one another
(p b 0.001); as the integration time increased, Tb.N decreased and
Tb.Thd and Tb.Spd increased. Tb.vBMD, BV/TVd and Tb.N measured
from the in situ HR-pQCT images were signiﬁcantly higher, and Tb.Spd
was signiﬁcantly lower, compared to the measurements from the
EV100 HR-pQCT image (p b 0.001). Tb.Thd measured from the IS100
and IS150 was signiﬁcantly lower than measurements from the EV100
HR-pQCT image (p b 0.001), but there was no difference between the
IS200 and EV100 measurement (p N 0.99).
3.2. Regression analyses in the common whole sample
Regression analyses for all evaluable regions are shown in Table 2.
There were strong correlations between BV/TV measured in the
micro-CT images and BV/TVd computed from both in situ and ex vivoes.
n situ 200 ms (IS200); ex vivo 100 ms (EV100); trabecular
ber (Tb.N), trabecular thickness (Tb.Th), trabecular spacing
75% percentile). Shaded areas indicate measurements that
T scans (all p b 0.001).
Table 2
Regression analysis for the HR-pQCT vs. micro-CT trabecular measurement across all
regions.
Sample r2 Intercept Slope RMSE Max. error
Bone volume/total volumed (1) (n= 104)
IS200 0.96 0.050 1.000 0.009 0.021
IS150 0.95 0.050 1.010 0.009 0.023
IS100 0.96 0.050 1.000 0.008 0.020
EV100 0.98 0.053 1.020 0.008 0.014
Trabecular number (mm−1) (n= 106)
IS200 0.61 0.805 0.347§ 0.15 0.46
IS150 0.44 0.921 0.263§ 0.18 0.59
IS100 0.33 0.941 0.217⁎,§ 0.19 0.67
EV100 0.79 0.678 0.469 0.11 0.30
Trabecular thicknessd (mm) (n= 107)
IS200 0.55 0.103 0.588 0.009 0.025
IS150 0.53 0.104 0.607 0.010 0.026
IS100 0.55 0.106 0.663 0.009 0.023
EV100 0.59 0.102 0.586 0.008 0.022
Trabecular spacingd (mm) (n = 107)
IS200 0.55 0.367 0.556 0.07 0.21
IS150 0.43 0.401 0.530 0.08 0.23
IS100 0.33 0.402 0.627 0.09 0.24
EV100 0.66 0.348 0.517 0.06 0.21
Abbreviations: in situ 100 ms (IS100); in situ 150 ms (IS150); in situ 200 ms (IS200); ex
vivo 100 ms (EV100); RMSE, root mean square error; max. error, maximum error from
the regression equation.
All r2 values are statistically signiﬁcant, p b 0.001. Comparison of the regression slopes be-
tween different HR-pQCT conditions: * p b 0.01 compared to IS200; § p b 0.001 compared
to EV100.
Table 3
Bone volume fraction regression data for thedifferentHR-pQCT conditions at the three dif-
ferent regions.
Sample Median (IQR) r2 Intercept Slope RMSE Max. error
Superior (n= 42)
Micro-CT 0.159 (0.139, 0.187)
IS200 0.105 (0.081, 0.126) 0.96 0.069 0.862§ 0.009 0.018
IS150 0.103 (0.083, 0.124) 0.96 0.070 0.857§ 0.009 0.019
IS100 0.105 (0.084, 0.124) 0.97 0.066 0.880§ 0.008 0.019
EV100 0.102 (0.082, 0.130) 0.97 0.063 0.927⁎,§ 0.007 0.020
Middle (n= 43)
Micro-CT 0.125 (0.097, 0.153)
IS200 0.078 (0.046, 0.103) 0.96 0.053 0.954§ 0.007 0.020
IS150 0.077 (0.046, 0.102) 0.96 0.052 0.962§ 0.008 0.022
IS100 0.077 (0.044, 0.100) 0.96 0.053 0.967§ 0.007 0.021
EV100 0.071 (0.044, 0.095) 0.99 0.051 1.030 0.004 0.013
Inferior (n= 21)
Micro-CT 0.100 (0.075, 0.123)
IS200 0.056 (0.036, 0.075) 0.98 0.035 1.160 0.005 0.010
IS150 0.058 (0.036, 0.075) 0.98 0.033 1.180 0.005 0.012
IS100 0.056 (0.035, 0.074) 0.98 0.035 1.160 0.005 0.010
EV100 0.050 (0.025, 0.071) 0.99 0.049 1.070 0.004 0.008
Abbreviations: in situ 100 ms (IS100); in situ 150 ms (IS150); in situ 200 ms (IS200); ex
vivo 100 ms (EV100); RMSE, root mean square error; max. error, maximum error from
the regression equation.
Median (interquartile range) bone volume fraction (1) is presented within each integra-
tion time at each region.
r2 values in bold are statistically signiﬁcant, p b 0.001. Comparison of the regression slopes
between the regions, within the same integration time: * p b 0.017 compared to the mid-
dle region; § p b 0.017 compared to the inferior region.
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the BV/TV versus BV/TVd regression slopes (p = 0.94) and the RMSEs
were similar (0.8–0.9%). The BV/TVd maximum errors obtained from
the in situ HR-pQCT images were similar (2–2.3%), and the value mea-
sured from the ex vivo HR-pQCT image was apparently lower (1.4%).
Weak tomoderate correlations were found between Tb.Nmeasured
in the micro-CT and the in situ HR-pQCT images; the correlations were
dependent on integration time (r2 = 0.33 for IS100 and r2 = 0.61 for
IS200) with signiﬁcant differences between the IS100 and IS200 regres-
sion slopes (p b 0.01). There seemed to be lower RMSE and maximum
error when the in situ integration time was increased from IS100 to
IS200 (0.19 to 0.15 mm−1 and 0.67 to 0.46 mm−1, respectively). The
Tb.N correlation improved further when measured by the ex vivo HR-
pQCT image in comparison to the micro-CT image (r2 = 0.79) and the
regression slope was signiﬁcantly different to that obtained with the
in situ comparisons (IS100, IS150 and IS200, p b 0.001). Tb.N measured
from the ex vivo HR-pQCT image also seemed to have lower RMSE
(0.11 mm−1) and maximum error (0.30 mm−1) compared measure-
ments from the in situ HR-pQCT images.
Moderate correlations were found for Tb.Thd estimated in all HR-
pQCT images with respect to the respective micro-CT measurements
(r2 = 0.53–0.59). There were no signiﬁcant differences between the
Tb.Thd regression slopes (p = 0.73), and the RMSE and maximum
error were all similar between the different HR-pQCT integration
times. Weak to moderate correlations were found for Tb.Spd estimated
in all HR-pQCT images with respect to Tb.Sp micro-CT measurements;
in situ correlations were dependent on the integration time (r2 = 0.33
for IS100 and r2 = 0.55 for IS200) and the correlation was found to in-
crease when measured in the ex vivo HR-pQCT image (r2 = 0.66).
There were no differences in Tb.Spd regression slopes (p = 0.64), and
the Tb.Spd RMSE and maximum error were all similar.
3.3. Regression analysis in superior, middle and inferior regions of the
calcaneus
We completed a regional analysis by grouping the 5 mm3 regions of
interests into superior, middle and inferior regions of the calcanealsamples (Fig. 1). A number of cubed regions from the inferior region
were removed as the analysis returned a negative vBMD. The results
within each of these regions for BV/TVd and Tb.N, the measurements
used to compute Tb.Thd and Tb.Spd from the HR-pQCT images, are
shown in Tables 3 and 4, respectively, with corresponding regression
plots in the Supplemental material 2. Data for Tb.Thd and Tb.Spd are
shown in the Supplemental materials 2 to 4.
BV/TVmeasuredbymicro-CT or BV/TVd estimatedbyHR-pQCTwere
highest in the superior region of the calcaneus in comparison to the
middle and inferior regions (p b 0.01 for all images), butwere not statis-
tically signiﬁcant between the middle and inferior regions (micro-CT, p
= 0.13; HR-pQCT, p= 0.16–0.29)(Table 3). There were strong correla-
tions at the superior, middle and inferior regions for BV/TVmeasured in
themicro-CT images and BV/TVd computed from both in situ and ex vivo
HR-pQCT images (r2 = 0.96–0.99, all p b 0.001). The superior and mid-
dle region regression slopes for BV/TVd were signiﬁcantly different to
the inferior region, within each respective integration time in situ (p b
0.017). The BV/TVd RMSE was below 1% in all regions. The maximum
error was 1–2% for the in situ and ex vivo HR-pQCT images at the supe-
rior, middle and inferior regions.
Tb.N measured by micro-CT was signiﬁcantly higher in the superior
and middle region compared to the inferior region (p= 0.02 and p=
0.03, respectively)(Table 4). A similar relationship was found for Tb.N
measured from the ex vivo HR-pQCT images (p = 0.003 and p =
0.005, respectively). In contrast, Tb.N measured from the in situ images
appeared to increase from the superior to inferior region, though these
values were largely not signiﬁcantly different between the regions,
apart from Tb.N being signiﬁcantly higher in the inferior region com-
pared to the superior region in the IS100 HR-pQCT images (p= 0.03).
The correlation for Tb.N measured frommicro-CT and HR-pQCT im-
ages was strongest in the superior region (r2 = 0.70–0.93, all p b 0.001)
compared to the middle region (r2 = 0.52–0.76, all p b 0.001). No cor-
relation was found for Tb.N in the inferior region (all p ≥ 0.21). The
strongest correlations were found for Tb.N measured in the ex vivo
HR-pQCT compared to the micro-CT image, and was the only HR-
pQCT image to be signiﬁcantly, albeit moderately, correlated with
micro-CT in the inferior region. All superior region regression slopes
Table 4
Trabecular number regression data for the different HR-pQCT conditions at the three dif-
ferent regions.
Sample Median (IQR) r2 Intercept Slope RMSE Max. error
Superior (n= 41)
Micro-CT 1.51 (1.37, 1.65)
IS200 1.87 (1.64, 2.10) 0.88 0.565 0.499⁎,§ 0.10 0.20
IS150 2.02 (1.79, 2.28) 0.82 0.601 0.454⁎,§ 0.12 0.28
IS100 2.36 (1.95, 2.59) 0.70 0.632 0.385§ 0.16 0.38
EV100 1.81 (1.55, 1.98) 0.93 0.461 0.584⁎,§ 0.07 0.17
Middle (n= 44)
Micro-CT 1.56 (1.37, 1.67)
IS200 1.99 (1.67, 2.56) 0.70 0.860 0.317§ 0.12 0.27
IS150 2.13 (1.89, 2.96) 0.59 0.916 0.264§ 0.15 0.35
IS100 2.49 (2.29, 3.44) 0.52 0.822 0.258§ 0.16 0.38
EV100 1.86 (1.51, 2.07) 0.76 0.680 0.460§ 0.11 0.24
Inferior (n = 21)
Micro-CT 1.45 (1.32, 1.47)
IS200 2.06 (1.88, 2.36) 0.00 1.430 −0.013 0.10 0.22
IS150 2.34 (2.19, 2.85) 0.05 1.510 −0.044 0.10 0.21
IS100 2.87 (2.61, 3.30) 0.08 1.560 −0.054 0.10 0.20
EV100 1.69 (1.13, 1.79) 0.50 1.110 0.196 0.07 0.20
Abbreviations: in situ 100 ms (IS100); in situ 150 ms (IS150); in situ 200 ms (IS200); ex
vivo 100 ms (EV100); RMSE, root mean square error; max. error, maximum error from
the regression equation.
Median (interquartile range) trabecular number (mm−1) is presented within each inte-
gration time at each region.
r2 values in bold are statistically signiﬁcant, p ≤ 0.001. Comparison of the regression slopes
between the regions, within the same integration time: * p b 0.017 compared to the mid-
dle region; § p b 0.017 compared to the inferior region.
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or regions,within each respective integration time. Allmiddle region re-
gression slopes were also signiﬁcantly different to the inferior region,
within each respective integration time. A lower RMSE and maximum
error were apparent at the superior and middle region with increasing
integration time in situ, but this was not apparent at the inferior region
in situ.
3.4. Bland-Altman method comparison
Bland-Altman plots for measurements in the superior, middle and
inferior regions are presented for BV/TVd and Tb.N in Fig. 3. Plots for
Tb.Thd and Tb.Spd are available in the supplemental material 5. BV/TVd
computed from the HR-pQCT images underestimated BV/TV measured
bymicro-CT. Themeanbiases for the in situ and ex vivoHR-pQCT images
were similar between the integration times and regions: approximately
4 to 5%. Tb.N measured by HR-pQCT images systematically
overestimated Tb.N measured from the micro-CT images. The mean
bias for Tb.N decreased as the integration time increased in the in situ
HR-pQCT images at all regions. The Tb.N mean bias was lower in the
ex vivo HR-pQCT images compared to the in situ HR-pQCT images.
The mean bias (±SD) for IS100 and IS150 increased from the superior
to inferior regions (IS100: superior =−0.85 ± 0.40 mm−1, inferior =
−1.46 ± 0.55 mm−1; IS150: superior =−0.56 ± 0.33 mm−1, inferior
= −0.98 ± 0.53 mm−1), whereas the mean bias for IS200 increased
from the superior to middle regions and was similar for the middle to
inferior regions (superior =−0.44 ± 0.28 mm−1, middle =−0.58 ±
0.42 mm−1, inferior =−0.63 ± 0.41 mm−1).
4. Discussion
This study describes the novel adaptation of HR-pQCT for the mea-
surement of calcaneal BV/TVd and microstructure. Calcaneus BV/TVd
and microstructure assessed at an isotropic 82 μm voxel size was vali-
dated against micro-CT at an isotropic 17 μm voxel size, which acted
as a ‘gold-standard’ reference. HR-pQCT BV/TVd had a strong correlation
across all scan conditions, explaining 95 to 98% of micro-CT BV/TV,when all regions were combined. This is important, as BV/TVd is a key
measurement to predict bone strength [21,22,37] and has a strong asso-
ciation with fracture risk [4,6].
The strong correlation and underestimation of BV/TVd that was
found with the calcaneus HR-pQCT scan images was consistent with
previous studies at the distal radius and distal tibia [22–24]. The lower
estimation of BV/TVd, derived from Tb.vBMD measurement by HR-
pQCT, could be causedby the global threshold used to deﬁnebone tissue
and lower signal-to-noise ratio resulting in a higher number of partial
volume voxels in the HR-pQCT images compared to the micro-CT im-
ages. It should also be remembered that the HR-pQCT measurements
were made in the intact bone, so that beam hardening artifacts caused
by the intact cortex and surrounding bone structures may have also im-
pacted on Tb.vBMDmeasurement [38]. Trabecular vBMDwas similar at
the different integration times. On removing the calcaneus from the
foot, the trabecular vBMD and BV/TVd were signiﬁcantly lower than
the in situ scans, even though the absolute difference was relatively
small. Dissection may have exposed the calcaneus to air bubbles that
were undetectable in the HR-pQCT images, or else there may have
been a reduction in image noise with removal of the surrounding
bones and soft tissue. Nonetheless, a regression equation that is inde-
pendent of integration time can be used to adjust calcaneus BV/TVd
computed from HR-pQCT images to that measured by micro-CT (Y =
1.010*X + 0.050).
Calcaneus Tb.N was systematically overestimated, and Tb.Thd and
Tb.Spd subsequently underestimated when measured by HR-pQCT
using the standard patient analysis, consistent with previous studies at
the radius and tibia [22–24]. It has been well established that the accu-
rate measurement of trabecular microstructure is dependent on the
spatial resolution [23], which was equivalent to the calcaneus Tb.Th
measured by micro-CT in the current study. The higher values of Tb.N
in purely trabecular samples measured by HR-pQCT compared to
micro-CT are in keeping with previous reports [22,23], probably
reﬂecting factors such as decreased signal-to-noise ratio and partial vol-
ume effects; factors that are exacerbated at the shorter integration
times as observed in our study. A similar increase in Tb.N for individual
specimens has been reported when comparing a 123 μm to 82 μm iso-
tropic voxel size [23]. BV/TVd may be less susceptible to such factors
as it is derived from Tb.vBMD, in which the averaging per cm−3 is likely
to suppress differences between integration times, as has been demon-
strated with direct BV/TV measurement [21,25,39].
The direct measurement of Tb.N is fundamental to determining
Tb.Spd and Tb.Thd using plate-model assumptions. The HR-pQCT indi-
rect patient analysis aims to preserve all trabeculae using a low global
threshold in order to measure Tb.N [40]. The caveat is that if an image
has a low signal-to-noise ratio, image noise could be categorized as
bone following application of the HR-pQCT threshold to segment to
bone and marrow phases [31]; this is the possible mechanism of the
greater overestimation of Tb.N at lower integration times and in
the inferior regions of the calcaneus. Increasing integration time
improved the accuracy of Tb.N in comparison to micro-CT, leading
also to an improvement in Tb.Spd accuracy. However, Tb.Thd was
not improved, due to its equal-weighted dependency on BV/TVd and
Tb.N. Weak correlations with Tb.Thd have been conﬁrmed in studies at
the radius and tibia despite strong correlations for BV/TVd and Tb.N
[23,24]; this study therefore further highlights a limitation in the
use of the plate-model assumptions using the ﬁrst generation
XtremeCT. A better signal-to-noise ratio, provided by a higher
Tb.BMD, was also reﬂected in the improved accuracy of Tb.N in
the denser superior region of the calcaneus than in the middle
and, particularly, inferior regions. Furthermore, the regionswith thinner
trabeculae (middle and inferior) could be more susceptible to
errors with the global threshold applied by the indirect HR-pQCT anal-
ysis, which could also explain differences in trabecular measurement
accuracy compared to other studies [21–24,40]. Other thresholds may
improve the accuracy; for example, in femoral head trabecular bone
Fig. 3. Bland-Altman plots for calcaneus bone volume fraction and trabecular number measured fromHR-pQCT images (IS100, IS150 and IS200, and EV100) compared to micro-CT image
at different regions (superior, middle and inferior). Abbreviations: in situ 100 ms (IS100); in situ 150 ms (IS150); in situ 200 ms (IS200); ex vivo 100 ms (EV100).
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becular thickness and spacing, though the overall impact was relatively
small [40].
The superior region scanned at 200ms integration time had compa-
rable correlation, slopes and accuracy for BV/TVd, Tb.N and Tb.Spd com-
pared to previous studies at the distal radius and distal tibia [22–24].
This is encouraging, as these validated protocols have been widely
used in clinical studies [4–9]. In addition to lower bone volume in the
middle and inferior regions, the signal-to-noise ratios may also be im-
pacted by the surrounding bones of the foot at these levels in affecting
the measurement of trabecular microstructure using HR-pQCT. The
more marked differences in Tb.N between the in situ and ex vivo scans
at the inferior region suggest that this may be the case. In the same re-
gion, noise is likely to have contributed to the fact that although the ex
vivo scan had similar Tb.N values to the micro-CT, the correlation was
still relativelyweak. Additionally, the poorer estimation at these regions
could be due to thinner trabeculae, which has been highlighted as an
issue in a previous study comparing plate- and rod-like trabeculae at
different voxel sizes [41].
The results reinforce using 200ms integration time for the calcaneus
HR-pQCT scans to compensate for the X-ray absorption from the
surrounding tissues. Practically, there would still be a low radiation
exposure per 110 slices (6 μSv per scan). However, scan duration
would be 4.2min (per 110 slices using the XtremeCT I), which is longer
than the distal radius and distal tibia scans (2.8 min). This would
increase the probability of participant movement andmay consequent-
ly affect measurement precision error. Precision error of HR-pQCTmeasurements at the calcaneus has not been established in vivo. Distal
radius and tibia error is already between 3 and 6% (least signiﬁcant
change 8 to 17%) for trabecular microstructure using rigid registration
at 100 ms integration time [42–44]. However, it can be questioned
whether the accuracy at lower integration times could be accepted to
improve reproducibility, which could be the case if BV/TVd, and possibly
other volumetric measurements, were of primary interest. The
comparison of different integration times in vivo therefore requires
investigation.
We have attempted to best represent in vivo conditions by obtaining
HR-pQCT scans in situ, with bones, soft tissue and marrow intact, to in-
form the clinical translation of the method. However, we recognize
there are several limitations to the study. First, and as has beendiscussed,
the study was free frommovement artifact, which would be expected to
affect measurement accuracy in vivo. Second, measurements may have
been impacted by the deterioration of bone mineral given the advanced
age of the donors.We found that BV/TVmeasured bymicro-CTwas com-
parable to previous studies that have evaluated similar regions and spec-
imens of a similar age and gender [20,45,46]; preliminary in vivo HR-
pQCT measurements suggest derived BV/TVs of up to 26% (unpublished
data) and this is likely to be greater in a younger cohort. Assessment of
calcaneus cortical bone was not undertaken due to the extremely thin
cortices observed in our cohort that affected the segmentation of the cal-
caneus cortical bone; whether this would be possible in younger speci-
mens remains to be determined. Third, in an attempt to broaden the
BV/TV range that was validated, we evaluated smaller cubic regions of
interest [25,30], potentially increasing errors between modalities that
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Fourth, micro-CT analysis primarily used a ﬁxed threshold, which was
adapted for 4 regions (same specimen). Others have used an adaptive
threshold for all samples [23] and this may be a factor in differences be-
tween the studies. Finally, we used the ﬁrst generation XtremeCT device
(isotropic voxel size = 82 μm, spatial resolution = 127 to 154 μm [47])
that uses plate model-assumptions to compute trabecular microstruc-
ture. The second generation XtremeCT device has a reported superior
spatial resolution (isotropic voxel size = 61 μm, spatial resolution =
95 μm), which includes more independent measurements and may im-
prove the direct estimation of trabecular microstructure [48]. Further-
more, the ﬁeld of view is slightly larger and the scan time is shorter,
whichmay better accommodate the quantiﬁcation of calcaneus trabecu-
lar microstructure in vivo.
5. Conclusion
In summary, we have developed a protocol to scan the calcaneus
using HR-pQCT that has achievedmeasurement correlation and accura-
cy comparable to previous validation studies performed at the distal ra-
dius and distal tibia. Here, scanning a superior region of the bonewith a
200 ms scan integration time for the quantiﬁcation of trabecular micro-
structure is preferred, based on the proposed protocol and integration
times investigated in this study. Investigating inferior regions of the cal-
caneus and using lower integration time appears inaccurate. Future de-
velopmentswill include the testing of HR-pQCT integration times in vivo
and determiningmeasurement precision error, bearing in mind the po-
tential formovement artifacts in longer scandurations. Such studieswill
determine whether calcaneus HR-pQCT scans could have a signiﬁcant
clinical utility in osteoporosis or podiatry research.
Disclosures
LMM, ED, MAP, JRR, GJK and EVM have nothing to declare. NV is an
employee of SCANCO Medical AG.
Acknowledgements
We acknowledge the technical assistance provided by Skelet.AL
(University of Shefﬁeld) in performing the micro-CT scans. We ac-
knowledgement funding from the MRC and Arthritis Research UK as
part of the MRC–Arthritis Research UK Centre for Integrated Research
into Musculoskeletal Ageing (MR/K006312/1) and the EPSRC Frontier
grant MULTISIM (EP/K03877X/1).
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.bone.2017.09.013.
References
[1] Consensus development conference: diagnosis, prophylaxis, and treatment of
osteoporosis, Am. J. Med. 94 (6) (1993) 646–650.
[2] J.A. Kanis, O. Johnell, A. Oden, H. Johansson, E. McCloskey, FRAX and the assessment
of fracture probability in men and women from the UK, Osteoporos. Int. 19 (4)
(2008) 385–397.
[3] K. Engelke, J.E. Adams, G. Armbrecht, P. Augat, C.E. Bogado, M.L. Bouxsein, D.
Felsenberg, M. Ito, S. Prevrhal, D.B. Hans, E.M. Lewiecki, Clinical use of quantitative
computed tomography and peripheral quantitative computed tomography in the
management of osteoporosis in adults: the 2007 ISCD ofﬁcial positions, Journal of
clinical densitometry: the ofﬁcial journal of the International Society for Clinical
Densitometry 11 (1) (2008) 123–162.
[4] M.H. Edwards, D.E. Robinson, K.A. Ward, M.K. Javaid, K. Walker-Bone, C. Cooper, E.M.
Dennison, Cluster analysis of bone microarchitecture from high resolution peripheral
quantitative computed tomography demonstrates two separate phenotypes associated
with high fracture risk in men and women, Bone 88 (2016) 131–137.
[5] J.Wang, E.M. Stein, B. Zhou, K.K. Nishiyama, Y.E. Yu, E. Shane, X.E. Guo, Deterioration
of trabecular plate-rod and cortical microarchitecture and reduced bone stiffness atdistal radius and tibia in postmenopausal women with vertebral fractures, Bone 88
(2016) 39–46.
[6] N. Vilayphiou, S. Boutroy, P. Szulc, B. van Rietbergen, F. Munoz, P.D. Delmas, R.
Chapurlat, Finite element analysis performed on radius and tibia HR-pQCT images
and fragility fractures at all sites in men, J. Bone Miner. Res. 26 (5) (2011) 965–973.
[7] J.N. Tsai, A.V. Uihlein, S.M. Burnett-Bowie, R.M. Neer, N.P. Derrico, H. Lee, M.L.
Bouxsein, B.Z. Leder, Effects of two years of teriparatide, denosumab, or both on
bone microarchitecture and strength (DATA-HRpQCT study), J. Clin. Endocrinol.
Metab. 101 (5) (2016) 2023–2030.
[8] H.M. Macdonald, K.K. Nishiyama, D.A. Hanley, S.K. Boyd, Changes in trabecular and
cortical bone microarchitecture at peripheral sites associated with 18 months of
teriparatide therapy in postmenopausal women with osteoporosis, Osteoporos.
Int. 22 (1) (2011) 357–362.
[9] S. Hansen, E.M. Hauge, J.-E.B. Jensen, K. Brixen, Differing effects of PTH 1–34, PTH 1–
84, and zoledronic acid on bone microarchitecture and estimated strength in post-
menopausal women with osteoporosis: an 18-month open-labeled observational
study using HR-pQCT, J. Bone Miner. Res. 28 (4) (2013) 736–745.
[10] C. Barnabe, H. Buie, M. Kan, E. Szabo, S.G. Barr, L. Martin, S.K. Boyd, Reproducible
metacarpal joint space width measurements using 3D analysis of images acquired
with high-resolution peripheral quantitative computed tomography, Med. Eng.
Phys. 35 (10) (2013) 1540–1544.
[11] W. Srikhum,W. Virayavanich, A.J. Burghardt, A. Yu, T. Link, J.B. Imboden, X. Li, Quan-
titative and semiquantitative bone erosion assessment on high-resolution peripher-
al quantitative computed tomography in rheumatoid arthritis, J. Rheumatol. 40 (4)
(2013) 408–416.
[12] A. Kroker, Y. Zhu, S.L. Manske, R. Barber, N. Mohtadi, S.K. Boyd, Quantitative in vivo
assessment of bone microarchitecture in the human knee using HR-pQCT, Bone 97
(2017) 43–48.
[13] M.L. Bouxsein, S.E. Radloff, Quantitative ultrasound of the calcaneus reﬂects the me-
chanical properties of calcaneal trabecular bone, J. Bone Miner. Res. 12 (5) (1997)
839–846.
[14] C.F. Njeh, T. Fuerst, E. Diessel, H.K. Genant, Is quantitative ultrasound dependent on
bone structure? A reﬂection, Osteoporos. Int. 12 (1) (2001) 1–15.
[15] A. Moayyeri, J.E. Adams, R.A. Adler, M.A. Krieg, D. Hans, J. Compston, E.M. Lewiecki,
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-
analysis, Osteoporos. Int. 23 (1) (2012) 143–153.
[16] M.L. Frost, G.M. Blake, I. Fogelman, Changes in QUS and BMD measurements with
antiresorptive therapy: a two-year longitudinal study, Calcif. Tissue Int. 69 (3)
(2014) 138–146.
[17] M.A. Paggiosi, R. Barkmann, C.C. Gluer, C. Roux, D.M. Reid, D. Felsenberg, M. Bradburn,
R. Eastell, A European, Multicenter comparison of quantitative ultrasound measure-
ment variables: the OPUS study, Osteoporos. Int. 23 (12) (2012) 2815–2828.
[18] M. Qiang, Y. Chen, K. Zhang, H. Li, H. Dai, Measurement of three-dimensional mor-
phological characteristics of the calcaneus using CT image post-processing, J Foot
Ankle Res 7 (19) (2014) 1–9.
[19] T.M. Malaquias, C. Silveira, W. Aerts, F. De Groote, G. Dereymaeker, J. Vander Sloten,
I. Jonkers, Extended foot-anklemusculoskeletal models for application inmovement
analysis, Comput Methods Biomech Biomed Engin 20 (2) (2017) 153–159.
[20] G. Diederichs, T.M. Link, M. Kentenich, K. Schwieger, M.B. Huber, A.J. Burghardt, S.
Majumdar, P. Rogalla, A.S. Issever, Assessment of trabecular bone structure of the
calcaneus using multi-detector CT: correlation with microCT and biomechanical
testing, Bone 44 (5) (2009) 976–983.
[21] B. Zhou, J. Wang, Y.E. Yu, Z. Zhang, S. Nawathe, K.K. Nishiyama, F.R. Rosete, T.M.
Keaveny, E. Shane, X.E. Guo, High-resolution peripheral quantitative computed to-
mography (HR-pQCT) can assess microstructural and biomechanical properties of
both human distal radius and tibia: ex vivo computational and experimental valida-
tions, Bone 86 (2016) 58–67.
[22] X.S. Liu, X.H. Zhang, K.K. Sekhon, M.F. Adams, D.J. McMahon, J.P. Bilezikian, E. Shane,
X.E. Guo, High-resolution peripheral quantitative computed tomography can assess
microstructural and mechanical properties of human distal tibial bone, J. Bone
Miner. Res. 25 (4) (2010) 746–756.
[23] W. Tjong, G.J. Kazakia, A.J. Burghardt, S. Majumdar, The effect of voxel size on high-
resolution peripheral computed tomography measurements of trabecular and corti-
cal bone microstructure, Med. Phys. 39 (4) (2012) 1893–1903.
[24] J.A. MacNeil, S.K. Boyd, Accuracy of high-resolution peripheral quantitative comput-
ed tomography for measurement of bone quality, Med. Eng. Phys. 29 (10) (2007)
1096–1105.
[25] P. Varga, E. Dall'Ara, D.H. Pahr, M. Pretterklieber, P.K. Zysset, Validation of an HR-
pQCT-based homogenized ﬁnite element approach using mechanical testing of
ultra-distal radius sections, Biomech. Model. Mechanobiol. 10 (4) (2011) 431–444.
[26] E.M. Lochmuller, N. Krefting, D. Burklein, F. Eckstein, Effect of ﬁxation, soft-tissues,
and scan projection on bonemineral measurements with dual energy X-ray absorp-
tiometry (DXA), Calcif. Tissue Int. 38 (3) (2001) 140–145.
[27] Y. Chen, E. Dall Ara, E. Sales, K. Manda, R. Wallace, P. Pankaj, M. Viceconti, Micro-CT
based ﬁnite element models of cancellous bone predict accurately displacement
once the boundary condition is well replicated: a validation study, J. Mech. Behav.
Biomed. Mater. 65 (2017) 644–651.
[28] A.I. Birkhold, H. Razi, R. Weinkamer, G.N. Duda, S. Checa, B.M. Willie, Monitoring in
vivo (re)modeling: a computational approach using 4D microCT data to quantify
bone surface movements, Bone 75 (2015) 210–221.
[29] Y. Lu, M. Boudiffa, E. Dall'Ara, I. Bellantuono, M. Viceconti, Development of a protocol
to quantify local bone adaptation over space and time: quantiﬁcation of reproduc-
ibility, J. Biomech. 49 (10) (2016) 2095–2099.
[30] E. Dall'Ara, P. Varga, D. Pahr, P. Zysset, A calibration methodology of QCT BMD for
human vertebral body with registered micro-CT images, Med. Phys. 38 (5) (2011)
2602–2608.
77L.M. Metcalf et al. / Bone 106 (2018) 69–77[31] A. Laib, P. Rüegsegger, Comparison of structure extraction methods for in vivo tra-
becular bone measurements, Comput. Med. Imaging Graph. 23 (1999) 69–74.
[32] A. Laib, T. Hildebrand, J. Häuselmann, P. Rüegsegger, Ridge number density: a new
parameter for in vivo bone structure analysis, Bone 21 (6) (1997) 541–546.
[33] A. Laib, P. Rüegsegger, Calibration of trabecular bone structure measurements of in
vivo three-dimensional peripheral quantitative computed tomography with 28-
um-resolution microcomputed tomography, Bone 24 (1) (1999) 35–39.
[34] A.M. Parﬁtt, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunier, S.M.
Ott, R.R. Recker, Bone histomorphometry: standardization of nomenclature, sym-
bols, and units. Report of the ASBMR histomorphometry nomenclature committee,
J. Bone Miner. Res. 2 (6) (1987) 595–610.
[35] T. Hildebrand, P. Rüegsegger, A newmethod for themodel-independent assessment
of thickness in three-dimensional images, J. Microsc. 185 (1) (1997) 67–75.
[36] J.M. Bland, D.G. Altman, Statistical methods for assessing agreement between two
methods of clinical measurement, Lancet 1 (8476) (1986) 307–310.
[37] G. Maquer, S.N. Musy, J. Wandel, T. Gross, P.K. Zysset, Bone volume fraction and fab-
ric anisotropy are better determinants of trabecular bone stiffness than other mor-
phological variables, J. Bone Miner. Res. 30 (6) (2015) 1000–1008.
[38] K. Sekhon, G.J. Kazakia, A.J. Burghardt, B. Hermannsson, S. Majumdar, Accuracy of
volumetric bone mineral density measurement in high-resolution peripheral quan-
titative computed tomography, Bone 45 (3) (2009) 473–479.
[39] M. Krause, O. Museyko, S. Breer, B. Wulff, C. Duckstein, E. Vettorazzi, C. Glueer, K.
Puschel, K. Engelke, M. Amling, Accuracy of trabecular structure by HR-pQCT com-
pared to gold standard muCT in the radius and tibia of patients with osteoporosis
and long-term bisphosphonate therapy, Osteoporos. Int. 25 (5) (2014) 1595–1606.
[40] A.J. Burghardt, G.J. Kazakia, S. Majumdar, A local adaptive threshold strategy for high
resolution peripheral quantitative computed tomography of trabecular bone, Ann.
Biomed. Eng. 35 (10) (2007) 1678–1686.[41] X.S. Liu, E. Shane, D.J. McMahon, X.E. Guo, Individual trabecula segmentation (ITS)-
based morphological analysis of microscale images of human tibial trabecular bone
at limited spatial resolution, J. Bone Miner. Res. 26 (9) (2011) 2184–2193.
[42] R. Ellouz, R. Chapurlat, B. Van Rietbergen, P. Christen, J.B. Pialat, S. Boutroy, Chal-
lenges in longitudinal measurements with HR-pQCT: evaluation of a 3D registration
method to improve bone microarchitecture and strength measurement reproduc-
ibility, Bone 63 (2014) 147–157.
[43] J.A. MacNeil, S.K. Boyd, Improved reproducibility of high-resolution peripheral
quantitative computed tomography for measurement of bone quality, Med. Eng.
Phys. 30 (6) (2008) 792–799.
[44] K. Engelke, B. Stampa, W. Timm, B. Dardzinski, A.E. de Papp, H.K. Genant, T. Fuerst,
Short-term in vivo precision of BMD and parameters of trabecular architecture at
the distal forearm and tibia, Osteoporos. Int. 23 (8) (2012) 2151–2158.
[45] F. Eckstein, M. Matsuura, V. Kuhn, M. Priemel, R. Muller, T.M. Link, E.M. Lochmuller,
Sex differences of human trabecular bone microstructure in aging are site-depen-
dent, J. Bone Miner. Res. 22 (6) (2007) 817–824.
[46] M. Rupprecht, P. Pogoda, M. Mumme, J.M. Rueger, K. Puschel, M. Amling, Bone
microarchitecture of the calcaneus and its changes in aging: a histomorphometric
analysis of 60 human specimens, J. Orthop. Res. 24 (4) (2006) 664–674.
[47] A.J. Burghardt, J.B. Pialat, G.J. Kazakia, S. Boutroy, K. Engelke, J.M. Patsch, A.
Valentinitsch, D. Liu, E. Szabo, C.E. Bogado, M.B. Zanchetta, H.A. McKay, E. Shane,
S.K. Boyd, M.L. Bouxsein, R. Chapurlat, S. Khosla, S. Majumdar, Multicenter precision
of cortical and trabecular bone quality measures assessed by high-resolution pe-
ripheral quantitative computed tomography, J. Bone Miner. Res. 28 (3) (2013)
524–536.
[48] S.L. Manske, Y. Zhu, C. Sandino, S.K. Boyd, Human trabecular bonemicroarchitecture
can be assessed independently of density with second generation HR-pQCT, Bone 79
(2015) 213–221.
